Anazole

Anastrozole 1mg

What is Anazole (Anastrozole) 1mg?

Anazole is a pharmaceutical product containing Anastrozole as its active ingredient, with each tablet providing a concentration of 1mg. Anastrozole belongs to a class of medications known as aromatase inhibitors and is primarily prescribed for the treatment of breast cancer in post-menopausal women. It plays a crucial role in managing hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer.

Indications:

Anazole is specifically indicated for the treatment of breast cancer in post-menopausal women. The key indications for Anazole encompass the following scenarios:

1. Post-Menopausal Women: Anazole is prescribed for women who have undergone menopause, which is characterized by the cessation of menstrual cycles. The hormonal changes associated with menopause play a role in the development and progression of certain types of breast cancer.

2. Hormone Receptor-Positive Breast Cancer: Anazole is particularly effective in the treatment of breast cancer where the cancer cells exhibit receptors for hormones, such as estrogen or progesterone. In this context, it is often referred to as hormone receptor-positive breast cancer.

3. Hormone Receptor Unknown Breast Cancer: Anazole is also indicated when the hormone receptor status of the breast cancer is unknown. This broadens its application to cases where the specific hormone receptors are not identified.

4. Locally Advanced Breast Cancer: Anazole is part of the therapeutic strategy for breast cancer that has advanced within the breast or nearby tissues but has not spread to distant parts of the body. This stage is known as locally advanced breast cancer.

5. Metastatic Breast Cancer: Anazole is employed in the treatment of breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, a stage known as metastatic breast cancer.

How Does it Work?

Anastrozole, the active ingredient in Anazole, works as an aromatase inhibitor. Aromatase is an enzyme involved in the synthesis of estrogen. By inhibiting aromatase, Anastrozole reduces the production of estrogen, which is known to fuel the growth of hormone receptor-positive breast cancer cells. Lowering estrogen levels helps slow down or inhibit the progression of the cancer.

Dosage and Administration:

Healthcare professionals determine the appropriate dosage and administration schedule for Anazole based on individual patient characteristics, the specific breast cancer condition, and the overall treatment plan. Anazole is typically administered orally, with or without food, as directed by the healthcare provider.

Onset of Action:

The onset of action of Anazole may vary among individuals. Patients are advised to adhere to the prescribed treatment schedule to maximize the therapeutic benefits.

Duration of Treatment:

The duration of Anazole treatment is determined by the healthcare provider based on individual response to therapy, overall treatment goals, and ongoing assessment of the patient's condition.

Monitoring and Follow-Up:

Regular medical monitoring and follow-up appointments are essential during Anazole treatment. Healthcare providers assess treatment efficacy, monitor potential side effects, and make any necessary adjustments to the treatment plan.

Presentation

30 tablets of 1mg each.

Old Pack Design: